Meeting with leadership

Making the Case for Digital Transformation

A framework for addressing cost, risk, and resistance to change to secure leadership buy-in

Written bySarah Kirsh, MSc
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

From cloud-based systems to AI-driven analytics, modernizing lab operations can greatly improve efficiency, accuracy, and scientific output. Yet convincing leadership to invest in these upgrades can prove challenging. Concerns often center around upfront costs, perceived risk, and the potential for workflow disruption. To secure buy-in, lab managers must frame proposals around leadership priorities, addressing strategic alignment, return on investment (ROI), risk mitigation, and change management. 

Frame the problem

Before introducing a solution, lab managers need to define the problem in a way that resonates with leadership. Start by identifying where current processes are falling short. Then, elevate these issues beyond the lab: how do they affect the organization’s broader goals?

For instance, manual sample tracking and data entry can reduce throughput, increase error rates, and erode confidence in test results. At the organizational level, this can lead to damaged client trust, delayed project timelines, and an increased risk of non-compliance. 

By positioning these challenges as obstacles to business growth, quality, and compliance, lab managers can help leadership view modernization as a strategic investment. 

Build a data-driven ROI

Once leadership understands what’s at stake, the next step is to demonstrate that the proposed technology is a financially sound investment. 

Quantify the time currently spent on routine administrative tasks as well as pre-analysis data preparation. In labs using outdated and siloed systems, scientists often spend hours compiling, cleaning, and formatting datasets before any analysis can begin. 

Highlight how modern tools—like integrated LIMS platforms and AI-enhanced analytics—can lessen this burden by centralizing data, standardizing outputs, and identifying trends. This helps labs manage larger workloads more effectively without increasing headcount and enables personnel to spend more time on higher-value activities. 

Where possible, include cost projections over time—such as expected savings or cost recovery over 12 to 24 months—and show how the proposed investment aligns with current budget plans. 

  Ready to modernize? Download our digital transformation guide!

Mitigate perceived risk

Leadership teams may hesitate not because they question the value of the technology, but because they fear the potential for large-scale disruption. A phased implementation plan can help address these concerns. Propose starting with a small pilot, such as rolling out cloud-based LIMS software in one lab or department. 

Define clear success metrics and build in checkpoints for progress reviews and adjustments. Early wins offer proof of concept and reduce perceived risk, creating momentum for broader implementation.

Address change management

Organizational resistance to change is a common concern, so it’s important to demonstrate how you will prepare and support staff throughout the transition. This might include developing a training plan, identifying key users to involve in early planning, and communicating how the changes will simplify—not complicate—everyday work. 

By presenting a thoughtful and proactive approach to change management, lab managers can help leadership feel confident that the project is positioned to succeed.  

Summary

Proposals for new technologies are most effective when they directly address leadership’s priorities. By clearly defining the problem, addressing financial and operational concerns, and presenting an implementation plan, lab managers can turn hesitation into lasting support. 

About the Author

  • sarah kirsch

    Sarah Kirsh, MSc, is a creative services writer for Lab Manager. Sarah holds a BSc in biochemistry and an MSc in molecular and cellular biology from the University of Guelph. Her thesis examined how inhibiting the neuropeptide Y1 and Y5 receptors impacts breast cancer cell proliferation, migration, and invasion in both hypoxia and normoxia. With a passion for science, Sarah enjoys exploring new topics and distilling scientific concepts into accessible and engaging stories. She can be reached at skirsh@labmanager.com.

    View Full Profile

Related Topics

Loading Next Article...

CURRENT ISSUE - October 2025

Turning Safety Principles Into Daily Practice

Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature

Lab Manager October 2025 Cover Image